儿童大环内酯类药物无反应性肺炎支原体肺炎早期预测列线图模型的构建与验证OA
Construction and validation of and early prediction nomogram model for macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children
目的:肺炎支原体是引发儿童社区获得性肺炎的最主要病原体之一.本研究旨在探讨儿童大环内酯类药物无反应性肺炎支原体肺炎(macrolide-unresponsive Mycoplasma pneumoniae pneumonia,MUMPP)发生的独立危险因素并构建列线图预测模型.方法:回顾性选取2023年1月至2024年5月在深圳市福田区第二人民医院儿科住院的800例肺炎支原体肺炎(Mycoplasma pneumoniae pneumonia,MPP)患儿作为模型开发队列,通过单因素分析和多因素Logistic回归分析识别导致MUMPP发生的独立危险因素,并据此构建列线图模型.以2024年10月至2025年6月收治的200例MPP患儿作为外部验证队列.根据受试者操作特征(receiver operating characteristic,ROC)曲线、决策曲线分析(decision curve analysis,DCA)及校准曲线检验,评估列线图诊断模型的区分度、准确性及临床适用性.结果:研究共纳入 1 000 例患儿,其中模型开发队列的 800 例中 700 例为普通肺炎支原体肺炎(general Mycoplasma pneumoniae pneumonia,GMPP),100例为MUMPP;验证队列的200例中GMPP 147例,MUMPP 53例.多因素Logistic回归分析显示,模型开发队列中C反应蛋白(C-reactive protein,CRP)[比值比(odds ratio,OR)=1.107,95%置信区间(confidence interval,CI)1.084~1.135,P<0.001]、白细胞介素-6(interleukin-6,IL-6)(OR=1.105,95%CI 1.044~1.174,P<0.001)、D-二聚体(D-dimer,D-D)(OR=82.070,95%CI 27.858~288.699,P<0.001)、丙氨酸氨基转移酶(alanine aminotransferase,ALT)(OR=1.069,95%CI 1.023~1.119,P=0.003)、胸部影像学检查中肺不张(OR=3.062,95%CI 1.144~8.378,P=0.027)、胸腔积液(OR=5.949,95%CI 2.011~17.866,P=0.001)及大环内酯类药物耐药基因检测阳性(OR=7.374,95%CI 2.644~21.261,P<0.001)等7个因素是MUMPP的独立危险因素,并据此构建列线图模型.列线图模型的ROC曲线下面积(area under the curve,AUC)在模型开发队列和验证队列中分别为0.973和0.904,具有较好的早期区分GMPP和MUMPP患儿的能力.校准曲线和决策曲线也证明了列线图预测模型的良好性能.结论:基于CRP、IL-6、D-D、ALT、肺不张、胸腔积液及大环内酯类药物耐药基因检测阳性,本研究建立的列线图模型能够早期、快速、有效地预测MPP患儿发生MUMPP的风险,可以作为早期评估儿童MUMPP发生风险的量化工具,帮助临床医生对儿童MUMPP进行早期识别.
Objective:Mycoplasma pneumoniae is one of the most common pathogens causing community-acquired pneumonia in children.This study aims to explore the independent risk factors for macrolide-unresponsive Mycoplasma pneumoniae pneumonia(MUMPP)in children and to construct a nomogram prediction model. Methods:A total of 800 children with Mycoplasma pneumoniae pneumonia(MPP)hospitalized in the Department of Pediatrics of The Second People's Hospital of Futian District,Shenzhen from January 2023 to May 2024 were retrospectively selected as the model development cohort.Univariate and multivariate Logistic regression analyses were used to identify independent risk factors for the occurrence of MUMPP,and a nomogram model was constructed based on these factors.Another 200 children with MPP admitted from October 2024 to June 2025 were used as the external validation cohort.Receiver operating characteristic(ROC)curves,decision curve analysis(DCA),and calibration curves were used to test and evaluate the discrimination,accuracy,and clinical applicability of the nomogram diagnostic model. Results:A total of 1 000 children were included in the study.Among the 800 cases in the model development cohort,700 were general Mycoplasma pneumoniae pneumonia(GMPP)and 100 progressed to MUMPP;among the 200 cases in the validation cohort,147 were GMPP and 53 were MUMPP.Multivariate logistic regression analysis showed that in the model development cohort,high-sensitivity C-reactive protein[CRP,odds ratio(OR)=1.107,95%confidence interval(CI)1.084 to 1.135,P<0.001],interleukin-6(IL-6)(OR=1.105,95%CI 1.044 to 1.174,P<0.001),D-dimer(D-D)(OR=82.070,95%CI 27.858 to 288.699,P<0.001),alanine aminotransferase(ALT)(OR=1.069,95%CI 1.023 to 1.119,P=0.003),atelectasis on chest imaging(OR=3.062,95%CI 1.144 to 8.378,P=0.027),pleural effusion(OR=5.949,95%CI 2.011 to 17.866,P=0.001),and positive detection of macrolide resistant genes(OR=7.374,95%CI 2.644 to 21.261,P<0.001)were 7 independent risk factors for MUMPP.A nomogram model was constructed based on these variables.The area under the ROC curve(AUC)of the nomogram model was 0.973 in the model development cohort and 0.904 in the validation cohort,indicating good ability to distinguish between GMPP and MUMPP in children at an early stage.The calibration curve and decision curve also demonstrated good performance of the nomogram prediction model. Conclusion:Based on CRP,IL-6,D-D,ALT,atelectasis,pleural effusion,and positive detection of macrolide resistant genes,the nomogram model established in this study can predict the risk of MUMPP in children with MPP early,rapidly,and effectively.It may serve as a quantitative tool for early assessment of the risk of MUMPP in children and help clinicians identify pediatric MUMPP at an early stage.
陈钟英;丁务高;高正炎;何樨
深圳市福田区第二人民医院儿科,深圳 518000深圳市福田区第二人民医院儿科,深圳 518000深圳市福田区第二人民医院儿科,深圳 518000深圳市福田区第二人民医院儿科,深圳 518000
医药卫生
大环内酯类药物无反应性肺炎支原体肺炎儿童临床特征列线图预测
macrolide-unresponsive Mycoplasma pneumoniae pneumoniachildrenclinical characteristicsnomogramprediction
《临床与病理杂志》 2026 (1)
47-56,10
深圳市福田区卫生健康系统科研项目资助(FTWS078).This work was supported by the Scientific Research Project Grant of the Shenzhen Futian District Health System,China(FTWS078).
评论